Oscar Health (NYSE:OSCR) CAO Victoria Baltrus Sells 1,523 Shares

Oscar Health, Inc. (NYSE:OSCR) CAO Victoria Baltrus sold 1,523 shares of Oscar Health stock in a transaction on Tuesday, June 2nd. The stock was sold at an average price of $21.94, for a total value of $33,414.62. Following the completion of the transaction, the chief accounting officer owned 214,589 shares in the company, valued at $4,708,082.66. The trade was a 0.70% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. The sale was made to cover tax withholding obligations related to the vesting of equity awards.

Oscar Health Stock Performance

Shares of NYSE OSCR opened at $23.54 on Friday. The company has a quick ratio of 1.11, a current ratio of 1.11 and a debt-to-equity ratio of 0.26. The stock has a market capitalization of $7.10 billion, a price-to-earnings ratio of -39.90, a PEG ratio of 1.43 and a beta of 2.37. The stock’s fifty day simple moving average is $18.15 and its 200 day simple moving average is $16.00. Oscar Health, Inc. has a 52-week low of $10.69 and a 52-week high of $25.58.

Oscar Health (NYSE:OSCR) last issued its earnings results on Wednesday, May 6th. The company reported $2.07 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.11 by $0.96. The business had revenue of $4.65 billion for the quarter, compared to analysts’ expectations of $4.90 billion. Oscar Health had a negative return on equity of 3.26% and a negative net margin of 0.30%.The company’s quarterly revenue was up 52.6% on a year-over-year basis. During the same period in the previous year, the firm posted $0.92 EPS. As a group, sell-side analysts forecast that Oscar Health, Inc. will post 0.47 earnings per share for the current fiscal year.

Key Stories Impacting Oscar Health

Here are the key news stories impacting Oscar Health this week:

• Positive Sentiment: Wells Fargo upgraded Oscar Health from “strong sell” to “hold”, suggesting the worst of the downside may be behind the stock even though the new $20 target still sits below the current share price. Zacks.com
• Positive Sentiment: A news item that Oscar Health co-founder is shifting into an advisory leadership role appears to be an internal transition rather than a disruptive change, which may be viewed as manageable by investors. Oscar Health Co-Founder Shifts to Advisory Leadership Role
• Neutral Sentiment: Oscar Health reported strong first-quarter EPS of $2.07, beating estimates by a wide margin, though revenue came in below expectations. The earnings beat supports the company’s fundamentals, but the softer revenue print limits the upside reaction.
• Neutral Sentiment: Multiple insiders, including CFO Richard Scott Blackley, Janet Liang, Adam Mcananey, Director Mario Schlosser, and CAO Victoria Baltrus, sold shares under pre-arranged 10b5-1 plans to cover tax withholding on vested equity awards. Because these were scheduled transactions, they are less alarming than discretionary selling, but the cluster of sales can still pressure sentiment.
• Negative Sentiment: The most notable insider sale was by Director Mario Schlosser, who sold 34,120 shares, adding to the perception that leadership is reducing exposure even if the trade was pre-planned.

Analyst Upgrades and Downgrades

A number of research analysts have recently weighed in on the company. Zacks Research upgraded Oscar Health from a “hold” rating to a “strong-buy” rating in a report on Thursday, May 7th. Barclays lifted their price target on Oscar Health from $21.00 to $30.00 and gave the company an “equal weight” rating in a report on Tuesday, May 26th. UBS Group lifted their price target on Oscar Health from $15.00 to $20.00 and gave the company a “neutral” rating in a report on Thursday, May 7th. Robert W. Baird lifted their price target on Oscar Health from $15.00 to $19.00 and gave the company a “neutral” rating in a report on Thursday, May 7th. Finally, Wolfe Research assumed coverage on Oscar Health in a report on Tuesday, May 5th. They set a “peer perform” rating on the stock. One equities research analyst has rated the stock with a Strong Buy rating, two have issued a Buy rating, eight have assigned a Hold rating and one has given a Sell rating to the stock. Based on data from MarketBeat, the company has an average rating of “Hold” and an average price target of $20.22.

Institutional Trading of Oscar Health

A number of institutional investors have recently bought and sold shares of OSCR. OneDigital Investment Advisors LLC increased its stake in shares of Oscar Health by 0.6% in the third quarter. OneDigital Investment Advisors LLC now owns 138,271 shares of the company’s stock worth $2,617,000 after purchasing an additional 779 shares during the period. Focus Partners Wealth increased its stake in shares of Oscar Health by 1.4% in the third quarter. Focus Partners Wealth now owns 57,787 shares of the company’s stock worth $1,094,000 after purchasing an additional 824 shares during the period. Equitable Holdings Inc. increased its stake in shares of Oscar Health by 7.0% in the fourth quarter. Equitable Holdings Inc. now owns 12,975 shares of the company’s stock worth $186,000 after purchasing an additional 850 shares during the period. Captrust Financial Advisors increased its stake in shares of Oscar Health by 2.0% in the fourth quarter. Captrust Financial Advisors now owns 45,754 shares of the company’s stock worth $657,000 after purchasing an additional 895 shares during the period. Finally, O Shaughnessy Asset Management LLC increased its stake in shares of Oscar Health by 5.6% in the fourth quarter. O Shaughnessy Asset Management LLC now owns 17,774 shares of the company’s stock worth $255,000 after purchasing an additional 938 shares during the period. Institutional investors and hedge funds own 75.70% of the company’s stock.

About Oscar Health

Oscar Health, trading on the New York Stock Exchange under the ticker OSCR, is a technology-driven health insurance company headquartered in New York, New York. Founded in 2012 by Mario Schlosser, Joshua Kushner and Kevin Nazemi, the company was built with the goal of simplifying healthcare coverage and enhancing member experience. Oscar leverages a proprietary digital platform to streamline plan enrollment, claims administration and member support, distinguishing itself in the individual, family and small group insurance markets.

The company’s primary products include on-exchange individual and family medical plans under the Affordable Care Act, off-exchange plans, as well as Medicare Advantage offerings.